1069137-73-0

Basic information

• Product Name: Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate
• Synonyms: (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylic Acid Succinimidyl Ester;NPCA;Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate;(2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylic Acid Succinimidyl Ester NPCA;(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-6-[(tetrahydro-2H-pyran-2-yl)oxy]-2H-1-benzopyran-2-carboxylic acid 2,5-dioxo-1-pyrrolidinyl ester
• CAS NO: 1069137-73-0
• Molecular Formula: C23H29NO7
• Molecular Weight: 431.47886
• Product Categories: Analytical Chemistry;Electrochemical Detection (HPLC Labeling Reagents);HPLC Labeling Reagents
• Mol File: 1069137-73-0.mol
• Article Data: 0

Chemical Properties

• Melting Point: 174 °C
• Appearance: /
• CAS DataBase Reference: Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate(1069137-73-0)
• EPA Substance Registry System: Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate(1069137-73-0)

Safety Data

• Hazardous Substances Data: 1069137-73-0(Hazardous Substances Data)

Usage

General Description

Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate is a compound that is often used in the field of chemistry and biochemistry for protein labeling and conjugation. It is a derivative of succinimide and is commonly used as a crosslinking reagent for proteins, peptides, and other biomolecules. The tetrahydro-2H-pyran-2-yloxy and tetramethylchroman-2-carboxylate groups present in the compound provide stability and solubility, making it suitable for a wide range of applications. This chemical plays a crucial role in various biochemical and medical research studies, particularly in the development of new drugs and diagnostics.